MedPage Today on MSN
PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma
First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
The top news to come out of skin cancer coverage this year for MHE focused on blood or marrow transplant recipients ...
The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...
In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...
Depending on the disease specifics, patients with melanoma may undergo pre- or post-surgical therapies. Skin melanoma, one of the most serious forms of skin cancer, poses a significant threat to ...
The Merlin CP-GEP Test, validated in the largest prospective gene expression profiling study in melanoma ( MERLIN_001 ), demonstrated that a High-Risk result identifies patients with a threefold ...
The Mayo Clinic says melanoma starts in the melanocytes, or the cells that make the pigment (melanin) giving skin its color. Melanoma starts on the skin that usually gets sun exposure, so arms, back, ...
Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma. HealthDay News — Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback